IRVINE, Calif., July 21, 2017 -- Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Eco Science Solutions, Inc. (“Eco Science” or the “Company”) (Other OTC:ESSI). Investors who purchased or otherwise acquired Eco Science shares from December 2, 2016 through May 19, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the July 24, 2017 lead plaintiff motion deadline.
If you purchased Eco Science shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at [email protected].
There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may also choose to take no action and remain a passive class member.
The Complaint alleges that during the Class Period, Eco Science made materially false and misleading statements, and/or failed to disclose, that its plan for strategic acquisitions lacked veracity. On May 19, 2017, the Securities & Exchange Commission announced a temporary suspension of the trading of the Company’s securities “because of concerns regarding the accuracy and adequacy of publicly disseminated information concerning, among other things, ESSI’s proposed acquisition of Ga-Du Bank, Inc.”
If you want to learn more about this lawsuit, or if you have questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at [email protected].
This press release may be considered Attorney Advertising in certain jurisdictions.
Contact Joon M. Khang, Esq. Telephone: 949-419-3834 Facsimile: 949-225-4474 [email protected]


Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Italy Fines Apple €98.6 Million Over App Store Dominance
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 



